Cargando…
Type 1 angiotensin receptor pharmacology: Signaling beyond G proteins
Drugs that inhibit the production of angiotensin II (AngII) or its access to the type 1 angiotensin receptor (AT(1)R) are prescribed to alleviate high blood pressure and its cardiovascular complications. Accordingly, much research has focused on the molecular pharmacology of AT(1)R activation and si...
Autores principales: | Oro, Cristina, Qian, Hongwei, Thomas, Walter G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112676/ https://www.ncbi.nlm.nih.gov/pubmed/17125841 http://dx.doi.org/10.1016/j.pharmthera.2006.10.001 |
Ejemplares similares
-
Heptahelical Receptor Signaling: Beyond the G Protein Paradigm
por: Hall, Randy A., et al.
Publicado: (1999) -
Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting
por: Speck, David, et al.
Publicado: (2022) -
Myogenic Vasoconstriction Requires Canonical G(q/11) Signaling of the Angiotensin II Type 1 Receptor
por: Cui, Yingqiu, et al.
Publicado: (2022) -
Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2022) -
Antibodies Expand the Scope of Angiotensin Receptor Pharmacology
por: Skiba, Meredith A., et al.
Publicado: (2023)